Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 3
2003 5
2004 3
2005 2
2006 2
2008 1
2009 2
2010 1
2011 3
2012 2
2014 2
2015 3
2016 1
2017 4
2018 4
2019 3
2020 1
2021 4
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, Dickinson M, Prica A, Major A, Hendrickson PG, Hopkins D, Ng A, Casulo C, Baron J, Roberts KB, Al Kendi J, Balogh A, Ricardi U, Torka P, Specht L, De Silva R, Pickard K, Blazin LJ, Henry M, Smith CM, Halperin D, Brady J, Brennan B, Senchenko MA, Reeves M, Hoppe BS, Terezakis S, Talaulikar D, Picardi M, Kirova Y, Fergusson P, Hawkes EA, Lee D, Doo NW, Barraclough A, Cheah CY, Ku M, Hamad N, Mutsando H, Gilbertson M, Marconi T, Viiala N, Maurer MJ, Eichenauer DA, Hoppe RT; GLOW Consortium. Binkley MS, et al. Among authors: baron j. J Clin Oncol. 2024 Mar 26:JCO2301655. doi: 10.1200/JCO.23.01655. Online ahead of print. J Clin Oncol. 2024. PMID: 38531001
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy.
Yegya-Raman N, Wright CM, LaRiviere MJ, Baron JA, Lee DY, Landsburg DJ, Svoboda J, Nasta SD, Gerson JN, Barta SK, Chong EA, Schuster SJ, Maity A, Facciabene A, Paydar I, Plastaras JP. Yegya-Raman N, et al. Among authors: baron ja. Clin Transl Radiat Oncol. 2023 Jan 20;39:100587. doi: 10.1016/j.ctro.2023.100587. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2023. PMID: 36718252 Free PMC article.
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration.
Baron JA, Wright CM, Maxwell R, Kim MM, Giap F, Vega RBM, Hoppe BS, LaRiviere MJ, Maity A, Plastaras JP, Paydar I. Baron JA, et al. Adv Radiat Oncol. 2022 Oct 3;8(1):101090. doi: 10.1016/j.adro.2022.101090. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36530648 Free PMC article.
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
Wright CM, Dreyfuss AD, Baron JA, Maxwell R, Mendes A, Barsky AR, Doucette A, Svoboda J, Chong EA, Jones JA, Maity A, Plastaras JP, Paydar I. Wright CM, et al. Among authors: baron ja. Adv Radiat Oncol. 2022 Jul 3;7(6):101016. doi: 10.1016/j.adro.2022.101016. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420208 Free PMC article.
Palliative Radiotherapy for Diffuse Large B-cell Lymphoma.
Wright CM, Koroulakis AI, Baron JA, Chong EA, Tseng YD, Kurtz G, LaRiviere M, Venigalla S, Jones JA, Maity A, Mohindra P, Plastaras JP, Paydar I. Wright CM, et al. Among authors: baron ja. Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):650-658. doi: 10.1016/j.clml.2021.05.007. Epub 2021 May 19. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34127417 Review.
49 results